Kernal Biologics
Latest round
- Seed
Last raised
- Feb 2022
Total raised
- $27M
Investors
- 7
About Kernal Biologics
, operates as a biotechnology company that creates mRNA therapies to cure diseases like COVID and cancer. Kernal Biologics uses deep learning to create mRNA therapies that will instruct cells on how to create their own medicine. The firm is currently developing mRNA technology that targets SARS-Cov-2 and opens an mRNA platform that will work on developing vaccines for COVID-19.0 platform and support its IND for immuno-oncology candidate KR-335.
Who invested in Kernal Biologics
7 investors across 3 rounds
See all investors in Kernal Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kernal Biologics
Who invested in Kernal Biologics?
Kernal Biologics has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kernal Biologics raised?
Kernal Biologics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Kernal Biologics last raise money?
Kernal Biologics's most recent round on record is a Seed, in Feb 2022.
What does Kernal Biologics do?
, operates as a biotechnology company that creates mRNA therapies to cure diseases like COVID and cancer.
Where is Kernal Biologics headquartered?
Kernal Biologics is headquartered in Cambridge, US.
Which VCs invest in companies like Kernal Biologics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kernal Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Kernal Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.